Abstract 1276: Lower thrombolysis, equal thrombectomy: reperfusion in stimulant-associated ischemic stroke, 2016-2023
Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)
DOI: 10.1161/svi270000_1276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von B. Cohen und 8 weiteren Autor:innen.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Cocaine and methamphetamine use are rising contributors to stroke in younger adults, and concerns about blood pressure lability and hemorrhage may create hesitancy toward thrombolysis. The rates at whcih stimulant-associated stroke patients receive reperfusion therapy at national scale has not yet been measured.
Methods
We analyzed the National Inpatient Sample, 2016-2023. The cohort comprised survey-weighted adult (18+) hospitalizations with a principal diagnosis of acute ischemic stroke (ICD-10-CM I63). Stimulant involvement was defined by any diagnosis of cocaine (F14, T40.5) or amphetamine-type (F15, T43.6) use or poisoning. Outcomes were receipt of intravenous thrombolysis (ICD-10-PCS 3E0x317), endovascular thrombectomy (EVT; 03CG family), either therapy, and in-hospital mortality. Survey-weighted logistic regression adjusted for age, sex, payer, income quartile, hospital characteristics, Charlson index, comorbidities, and year. Sensitivity analyses modeled each substance separately, restricted to ages 18-54, adjusted for coded NIHSS (R29.7xx, available in 49%), restricted to the clearly reperfusion-eligible severity band (NIHSS 4-25), excluded discharges against medical advice (AMA), and excluded transfers out. Analyses used Stata 18.
Results
Of 4,267,214 weighted hospitalizations, 88,170 (2.1%) involved stimulant use. Stimulant-associated stroke patients were 15 years younger (mean 54.8 vs 70.3 years) with higher coded severity (mean NIHSS 7.4 vs 6.3). Stimulant use was associated with lower adjusted odds of reperfusion (aOR 0.90, 95% CI 0.86-0.94), driven by thrombolysis (aOR 0.90) rather than EVT (aOR 0.97, 95% CI 0.90-1.04). The deficit was present for cocaine (aOR 0.88) and methamphetamine (aOR 0.92) separately, persisted in ages 18-54 (aOR 0.90), widened with NIHSS adjustment (aOR 0.80, 95% CI 0.76-0.85) and in the eligible-severity band (aOR 0.79, 95% CI 0.74-0.84), and was unchanged after excluding AMA discharges (aOR 0.91). AMA discharge was itself four times more common with stimulant use (12.9% vs 2.9%). Stimulant use was independently associated with higher in-hospital mortality (aOR 1.14, 95% CI 1.04-1.25).
Conclusions
In the first national analysis of reperfusion receipt in stimulant-associated stroke, stimulant users had consistently lower odds of thrombolysis despite younger age and greater coded severity, alongside higher mortality and a fourfold AMA-discharge excess. Presentation delay and undocumented contraindications are not observable in claims data, but the severity-adjusted, refusal-robust pattern suggests a treatment gap in a young, high-risk population.
Zitieren
APA
Cohen, B., Zaremba, S., Allen, B., Singh, S., Majmundar, A., Randhawa, G., Gupta, M., Signore, M. D., & Durkin, M. (2026). Abstract 1276: Lower thrombolysis, equal thrombectomy: reperfusion in stimulant-associated ischemic stroke, 2016-2023. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1276
Vancouver
Cohen B, Zaremba S, Allen B, Singh S, Majmundar A, Randhawa G, et al. Abstract 1276: Lower thrombolysis, equal thrombectomy: reperfusion in stimulant-associated ischemic stroke, 2016-2023. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1276
BibTeX
@article{Cohen2026,
author = {Cohen, B. and Zaremba, S. and Allen, B. and Singh, S. and Majmundar, A. and Randhawa, G. and Gupta, M. and Signore, M. Del and Durkin, M.},
title = {Abstract 1276: Lower thrombolysis, equal thrombectomy: reperfusion in stimulant-associated ischemic stroke, 2016-2023},
journal = {Stroke: Vascular and Interventional Neurology},
year = {2026},
volume = {6},
number = {Suppl_1},
doi = {10.1161/svi270000_1276}
}
EUVIMED